Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, John M. Kane, MD, and Rebecca S. Roma, MD, discuss clinical assessment of extrapyramidal symptoms (EPS), antiparkinsonian drugs, and tardive dyskinesia (TD). They review differentiating between TD and EPS, identify tools for diagnosing TD, and provide some important clinical pearls and evidence-based reasons for choosing different medications for treating EPS and TD.
John M. Kane, MD
Professor and Chairman
Department of Psychiatry
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Glen Oaks, New York
Rebecca S. Roma, MD
Slides from a presentation that educates clinicians on how to formulate an approach to treat patients with bipolar disorder.
Slides from a presentation that educates clinicians on how to formulate an approach to diagnose patients with bipolar disorder.
Clinical Care Options (CCO) commentary by Jonathan M. Meyer, MD, on VMAT2 inhibitors in TD and anticholinergic exacerbation of TD symptoms.
Slides from a presentation that formulates an approach to diagnose patients with tardive dyskinesia.